Literature DB >> 7588966

A family with combined Farber and Sandhoff, isolated Sandhoff and isolated fetal Farber disease: postnatal exclusion and prenatal diagnosis of Farber disease using lipid loading tests on intact cultured cells.

T Levade1, H Enders, M Schliephacke, K Harzer.   

Abstract

UNLABELLED: An earlier described patient with combined sphingolipidoses, Farber and Sandhoff disease, had two healthy older brothers and two further sibs, one with Sandhoff disease and one (a fetus) with Farber disease, showing segregation of the respective genes. The prenatal diagnosis in the latter was performed using lipid (sphingomyelin and glucosylceramide) loading tests on the cultured amniotic fluid cells. After 1-3 days of incubation the cells' lipid extract revealed radioactive ceramide to be released and highly accumulated. The deficiency in acid ceramidase was known from the patient with the combined diseases. Confirmation of the prenatal Farber diagnosis was done by similar loading tests on the fetal fibroblasts and by analysis of liver lipids of the less than 18-week-old fetus.
CONCLUSION: This is the first report on the use of lipid loading tests on intact cultured cells for prenatal diagnosis of Farber disease. The postnatal diagnosis of Farber disease can also be readily made using those tests, as was shown in four further cases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588966     DOI: 10.1007/BF02079069

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease.

Authors:  P Leinekugel; S Michel; E Conzelmann; K Sandhoff
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

2.  Prenatal diagnosis of Farber's disease.

Authors:  A H Fensom; P F Benson; B R Neville; H W Moser; A E Moser; J T Dulaney
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

3.  [Enzymatic studies on the blood of carriers of a Tay-Sachs disease variant (variant O)].

Authors:  K Harzer; K Sandhoff; H Schall; F Kollmann
Journal:  Klin Wochenschr       Date:  1971-11-01

4.  The in situ degradation of ceramide, a potential lipid mediator, is not completely impaired in Farber disease.

Authors:  T Levade; M C Tempesta; R Salvayre
Journal:  FEBS Lett       Date:  1993-08-30       Impact factor: 4.124

5.  Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms.

Authors:  B Kustermann-Kuhn; K Harzer
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  Role of lysosomal acid ceramidase in the metabolism of ceramide in human skin fibroblasts.

Authors:  W W Chen; A B Moser; H W Moser
Journal:  Arch Biochem Biophys       Date:  1981-05       Impact factor: 4.013

Review 7.  Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.

Authors:  K Harzer; B C Paton; A Poulos; B Kustermann-Kuhn; W Roggendorf; T Grisar; M Popp
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

8.  Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.

Authors:  V Bradová; F Smíd; B Ulrich-Bott; W Roggendorf; B C Paton; K Harzer
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

9.  A case of combined Farber and Sandhoff disease.

Authors:  C Fusch; R Huenges; H W Moser; A C Sewell; W Roggendorf; B Kustermann-Kuhn; A Poulos; W F Carey; K Harzer
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

View more
  3 in total

1.  Accumulation of ordered ceramide-cholesterol domains in farber disease fibroblasts.

Authors:  Natalia Santos Ferreira; Michal Goldschmidt-Arzi; Helena Sabanay; Judith Storch; Thierry Levade; Maria Gil Ribeiro; Lia Addadi; Anthony H Futerman
Journal:  JIMD Rep       Date:  2013-07-12

2.  Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.

Authors:  J Tohyama; Y Oya; T Ezoe; M T Vanier; H Nakayasu; N Fujita; K Suzuki
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 3.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.